What CVD risk factors predict self-perceived risk of having a myocardial infarction? A cross-sectional study [0.03%]
哪些CVD危险因素可以预测个人的心肌梗死发病风险？一项横断面研究
Åsa Grauman,Liisa Byberg,Jorien Veldwijk et al.
Åsa Grauman et al.
Background: This study aims to identify predictors of self-perceived risk of myocardial infarction (MI). Methods: Among 564 men and wom...
Epidemiology of cardiovascular disease and its risk factors among refugees and asylum seekers: Systematic review and meta-analysis [0.03%]
关于难民和寻求庇护者心血管疾病及其危险因素的流行病学：系统评价和meta分析
Tala Al-Rousan,Rawan AlHeresh,Altaf Saadi et al.
Tala Al-Rousan et al.
Background: This is the first systematic review and meta-analysis assessing cardiovascular disease incidence and risk factors among refugees and asylum seekers. ...
Is colchicine the holy grail for treating inflammation and reducing cardiovascular risk? [0.03%]
科利奇碱是治疗炎症和降低心血管风险的“圣杯”吗？
Krzysztof J Filipiak,Stanisław Surma
Krzysztof J Filipiak
Association of second trimester uterine artery Doppler parameters with maternal hypertension 2-7 years after delivery [0.03%]
第二孕期子宫动脉多普勒参数与产后2-7年母亲高血压的相关性研究
Eliza C Miller,Benjamin Carper,Natalie A Bello et al.
Eliza C Miller et al.
Background: Reduced uterine artery compliance is associated with adverse pregnancy outcomes (APOs) and may indicate underlying maternal cardiovascular pathology. We investigated associations between second trimester uteri...
Joji Ishikawa,Satoshi Seino,Akihiko Kitamura et al.
Joji Ishikawa et al.
Background: Although an elevated systolic blood pressure (SBP) is associated with cognitive dysfunction, BP may decrease with advanced cognitive dysfunction; therefore, we attempted to identify the turning point in the re...
Letter to the Editor on "Why is salt-sensitivity of blood pressure, a known cardiovascular risk factor, not treated?" [0.03%]
关于“为何已知的心血管风险因素血压盐敏感性没有得到治疗？”的读者来信
Leidy Johana Diaz-Novoa,David Giovanny Ulloa-Ramírez,Viviana Camila Sánchez-Moreno et al.
Leidy Johana Diaz-Novoa et al.
Projecting the long-term benefits of single pill combination therapy for patients with hypertension in five countries [0.03%]
预测五国高血压患者单片复方治疗长期效益
Claudio Borghi,Jiguang Wang,Anton V Rodionov et al.
Claudio Borghi et al.
Objective: To project the 10-year clinical outcomes associated with single pill combination (SPC) therapies compared with multi-pill regimens for the management of hypertension in five countries (Italy, Russia, China, Sou...
Do clinical trial data suggest a role for SGLT2-inhibitors in primary prevention of heart failure and chronic kidney disease? [0.03%]
临床试验数据能否支持钠葡萄糖协同转运蛋白-2抑制剂用于预防心力衰竭和慢性肾脏病？
Jan A Staessen,Stefan Janssens,Frans Van de Werf
Jan A Staessen
Commentary: " Lower is Better" - SPRINTing to STEPping up hypertension research? An historical perspective on hypertension trials [0.03%]
评论：“较低较好”——SPRINT促进STEP研究？基于降压临床试验的历史思考
Yu-Ling Yu,Jan A Staessen
Yu-Ling Yu